| 4.3 |
12.8 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 4.1 |
8.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.4 |
10.1 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 2.7 |
8.2 |
GO:0046959 |
habituation(GO:0046959) |
| 2.5 |
7.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.5 |
9.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 2.5 |
7.4 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.4 |
7.3 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 2.4 |
7.1 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.3 |
2.3 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 2.3 |
6.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.0 |
10.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.0 |
12.0 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 2.0 |
4.0 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 2.0 |
5.9 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.0 |
2.0 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 1.9 |
9.6 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 1.9 |
5.7 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.9 |
5.6 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 1.9 |
1.9 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.9 |
5.6 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 1.8 |
7.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.8 |
1.8 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
| 1.8 |
7.1 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.8 |
1.8 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.8 |
8.9 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 1.7 |
24.2 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.7 |
8.6 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.7 |
3.4 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 1.7 |
10.0 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.7 |
11.6 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 1.7 |
6.6 |
GO:0021586 |
pons maturation(GO:0021586) |
| 1.6 |
6.5 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.6 |
1.6 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 1.6 |
4.8 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.6 |
6.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.6 |
9.3 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 1.5 |
4.6 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.5 |
6.0 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 1.5 |
6.0 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.5 |
7.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 1.5 |
1.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.4 |
5.8 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.4 |
18.7 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.4 |
1.4 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.4 |
1.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.4 |
4.2 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.4 |
22.0 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 1.4 |
11.0 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.4 |
1.4 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 1.4 |
4.1 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.4 |
5.4 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.4 |
20.3 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.3 |
1.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.3 |
4.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 1.3 |
3.9 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.3 |
1.3 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 1.3 |
14.4 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 1.3 |
5.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 1.3 |
6.5 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.3 |
1.3 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 1.3 |
2.5 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 1.3 |
5.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.3 |
3.8 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.3 |
6.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 1.3 |
1.3 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 1.3 |
2.5 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 1.2 |
4.9 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.2 |
4.8 |
GO:0009597 |
detection of virus(GO:0009597) |
| 1.2 |
1.2 |
GO:0002832 |
negative regulation of response to biotic stimulus(GO:0002832) |
| 1.2 |
4.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.2 |
1.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.1 |
3.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.1 |
5.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 1.1 |
4.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.1 |
6.8 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.1 |
3.4 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.1 |
1.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.1 |
4.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.1 |
3.3 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.1 |
3.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.1 |
10.9 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.1 |
12.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.1 |
3.3 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.1 |
6.5 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 1.1 |
3.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 1.1 |
1.1 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 1.1 |
4.3 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.1 |
3.2 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.1 |
4.2 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 1.0 |
8.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.0 |
3.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
| 1.0 |
2.1 |
GO:0051580 |
regulation of neurotransmitter uptake(GO:0051580) |
| 1.0 |
2.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.0 |
2.1 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 1.0 |
23.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 1.0 |
5.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.0 |
2.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 1.0 |
9.1 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 1.0 |
4.0 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 1.0 |
1.0 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 1.0 |
4.0 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 1.0 |
4.0 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 1.0 |
3.0 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 1.0 |
1.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.0 |
6.9 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 1.0 |
3.0 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 1.0 |
5.8 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 1.0 |
3.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.0 |
6.8 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.0 |
1.0 |
GO:0002866 |
positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
| 1.0 |
7.7 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 1.0 |
3.8 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 1.0 |
4.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.9 |
4.7 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.9 |
5.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.9 |
5.7 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.9 |
1.9 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.9 |
16.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.9 |
5.6 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.9 |
2.8 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.9 |
5.6 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.9 |
2.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.9 |
4.6 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.9 |
4.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.9 |
2.8 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.9 |
5.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.9 |
0.9 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.9 |
3.7 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.9 |
4.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.9 |
4.6 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.9 |
1.8 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.9 |
4.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.9 |
10.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.9 |
2.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.9 |
3.6 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.9 |
1.8 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.9 |
8.9 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.9 |
3.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.9 |
2.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.9 |
7.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.9 |
2.6 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.9 |
2.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.9 |
2.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.9 |
2.6 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.9 |
2.6 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.9 |
3.5 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.9 |
1.7 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
| 0.9 |
2.6 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.9 |
1.7 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.9 |
2.6 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.9 |
6.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.8 |
14.4 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.8 |
14.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.8 |
0.8 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.8 |
2.5 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.8 |
4.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.8 |
2.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.8 |
6.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.8 |
0.8 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.8 |
3.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.8 |
2.5 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.8 |
9.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.8 |
2.4 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.8 |
4.0 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.8 |
3.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 |
8.0 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.8 |
7.2 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.8 |
3.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.8 |
1.6 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.8 |
7.2 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.8 |
0.8 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.8 |
11.7 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.8 |
3.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.8 |
5.4 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
4.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.8 |
3.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.8 |
0.8 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.8 |
3.0 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 |
1.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.8 |
2.3 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.8 |
2.3 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.7 |
1.5 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.7 |
10.5 |
GO:0031269 |
pseudopodium assembly(GO:0031269) |
| 0.7 |
0.7 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.7 |
14.7 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.7 |
3.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 |
0.7 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.7 |
4.4 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.7 |
6.6 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.7 |
0.7 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.7 |
5.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.7 |
8.7 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.7 |
5.8 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 0.7 |
2.9 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.7 |
1.4 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.7 |
2.2 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.7 |
1.4 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.7 |
3.6 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.7 |
3.6 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 |
2.9 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.7 |
2.8 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.7 |
4.3 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.7 |
3.6 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.7 |
4.3 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.7 |
0.7 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.7 |
8.5 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.7 |
2.1 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.7 |
4.2 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.7 |
1.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.7 |
0.7 |
GO:0051238 |
sequestering of metal ion(GO:0051238) |
| 0.7 |
2.8 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.7 |
2.1 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.7 |
4.8 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.7 |
4.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.7 |
2.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.7 |
0.7 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.7 |
0.7 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.7 |
3.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.7 |
5.3 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.7 |
6.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.7 |
2.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 |
4.0 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.7 |
0.7 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.7 |
9.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.7 |
4.6 |
GO:0002524 |
hypersensitivity(GO:0002524) |
| 0.7 |
2.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.6 |
5.2 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
3.2 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.6 |
2.6 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.6 |
1.3 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.6 |
0.6 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.6 |
2.5 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.6 |
1.9 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.6 |
1.9 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 |
2.5 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.6 |
5.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.6 |
1.2 |
GO:0035793 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.6 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.6 |
1.9 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.6 |
2.5 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
1.2 |
GO:0002863 |
positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
| 0.6 |
1.2 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.6 |
2.4 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.6 |
2.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.6 |
5.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.6 |
2.4 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.6 |
0.6 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.6 |
1.8 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.6 |
2.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 |
11.9 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.6 |
6.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.6 |
1.2 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.6 |
3.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.6 |
3.5 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.6 |
7.0 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.6 |
1.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.6 |
3.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
0.6 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.6 |
3.5 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.6 |
1.7 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.6 |
1.7 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.6 |
2.9 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.6 |
1.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.6 |
6.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.6 |
6.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.6 |
1.7 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.6 |
6.8 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.6 |
16.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.6 |
2.2 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.6 |
1.7 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 |
1.7 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.6 |
2.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 |
2.2 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.5 |
5.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.5 |
0.5 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.5 |
0.5 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.5 |
4.3 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.5 |
1.6 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 |
4.3 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.5 |
8.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.5 |
1.1 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.5 |
3.2 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 |
1.6 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.5 |
3.8 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.5 |
3.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.5 |
2.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.5 |
2.7 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.5 |
2.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.5 |
5.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.5 |
0.5 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
2.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.5 |
1.6 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.5 |
2.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.5 |
1.0 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.5 |
3.6 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.5 |
0.5 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) regulation of parathyroid hormone secretion(GO:2000828) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.5 |
2.1 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 |
2.1 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.5 |
2.6 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.5 |
1.5 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.5 |
1.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.5 |
34.7 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.5 |
1.5 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.5 |
5.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.5 |
1.0 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.5 |
3.5 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.5 |
3.0 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.5 |
0.5 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.5 |
0.5 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.5 |
2.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.5 |
1.0 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.5 |
3.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 |
10.8 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.5 |
3.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.5 |
3.9 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.5 |
1.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.5 |
1.5 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.5 |
1.5 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
1.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.5 |
9.6 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.5 |
1.4 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.5 |
4.8 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.5 |
3.4 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.5 |
2.4 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.5 |
4.3 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.5 |
0.5 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.5 |
2.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.5 |
2.4 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.5 |
6.6 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 |
4.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.5 |
1.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.5 |
1.8 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.5 |
5.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.5 |
0.5 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 0.5 |
0.5 |
GO:0002488 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.5 |
2.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.5 |
2.7 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) negative regulation of platelet aggregation(GO:0090331) |
| 0.5 |
0.9 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.4 |
1.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.4 |
0.4 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.4 |
5.7 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.4 |
2.6 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.4 |
1.3 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.4 |
10.1 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.4 |
3.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
2.6 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.4 |
1.7 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.4 |
1.7 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.4 |
3.5 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.4 |
0.9 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.4 |
0.9 |
GO:0035754 |
negative regulation of protein import into nucleus, translocation(GO:0033159) B cell chemotaxis(GO:0035754) |
| 0.4 |
1.7 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 |
10.4 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 |
1.3 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.4 |
0.9 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.4 |
2.2 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.4 |
1.3 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.4 |
2.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.4 |
3.0 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.4 |
1.3 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.4 |
3.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.4 |
1.7 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 |
0.8 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.4 |
2.5 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.4 |
1.3 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.4 |
0.8 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.4 |
11.6 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.4 |
5.0 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.4 |
0.8 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
1.7 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.4 |
0.8 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.4 |
2.5 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.4 |
0.4 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.4 |
0.8 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 |
0.4 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.4 |
3.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.4 |
7.7 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.4 |
5.7 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.4 |
1.2 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.4 |
1.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.4 |
1.6 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 |
4.4 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.4 |
2.0 |
GO:0061081 |
macrophage cytokine production(GO:0010934) positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.4 |
2.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.4 |
0.8 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.4 |
0.8 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.4 |
1.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 |
1.6 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.4 |
0.4 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
| 0.4 |
0.8 |
GO:2000347 |
positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.4 |
3.9 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.4 |
1.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.4 |
1.2 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.4 |
0.8 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.4 |
0.8 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.4 |
1.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.4 |
2.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 |
3.4 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.4 |
1.1 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.4 |
1.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 |
1.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.4 |
0.8 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.4 |
2.6 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
0.4 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.4 |
3.4 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.4 |
7.1 |
GO:0086026 |
atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
| 0.4 |
2.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.4 |
2.2 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.4 |
3.0 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.4 |
3.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.4 |
1.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
1.5 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.4 |
0.7 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.4 |
0.4 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 |
0.4 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.4 |
0.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.4 |
1.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.4 |
1.4 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.4 |
1.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.4 |
3.2 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.4 |
0.7 |
GO:1904058 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) positive regulation of sensory perception of pain(GO:1904058) |
| 0.4 |
1.1 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.3 |
1.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.7 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.3 |
1.0 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
0.3 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.3 |
1.7 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.3 |
0.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.3 |
0.3 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.3 |
2.4 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.3 |
1.4 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 |
1.0 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.3 |
0.7 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.3 |
0.3 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.3 |
3.4 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.3 |
2.0 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.3 |
0.3 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.3 |
0.7 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
2.7 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.3 |
0.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.3 |
5.3 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.3 |
1.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 |
1.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
1.6 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.3 |
3.5 |
GO:0001964 |
startle response(GO:0001964) |
| 0.3 |
3.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.3 |
2.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.3 |
1.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
1.0 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.3 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 |
2.2 |
GO:0070841 |
inclusion body assembly(GO:0070841) |
| 0.3 |
2.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 |
1.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
1.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 |
6.6 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
0.9 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.3 |
0.9 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 |
4.7 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
1.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
0.9 |
GO:0010970 |
establishment of localization by movement along microtubule(GO:0010970) |
| 0.3 |
2.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.3 |
0.9 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 |
4.0 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.3 |
1.5 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.3 |
2.7 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.3 |
10.4 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.3 |
1.2 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.3 |
2.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
0.3 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
0.3 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.3 |
7.0 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.3 |
1.8 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.3 |
1.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 |
0.3 |
GO:0002886 |
regulation of myeloid leukocyte mediated immunity(GO:0002886) |
| 0.3 |
1.5 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.3 |
0.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.3 |
1.5 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.3 |
0.9 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.3 |
0.3 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.3 |
0.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.3 |
14.6 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.3 |
5.9 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.3 |
0.3 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.3 |
2.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.3 |
1.8 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
0.3 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.3 |
0.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 |
2.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
2.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
0.3 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
10.4 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.3 |
1.4 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.3 |
0.6 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.3 |
2.0 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
1.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
0.3 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.3 |
0.8 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.3 |
1.7 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.3 |
1.4 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
1.1 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
0.6 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.3 |
8.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.3 |
3.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
0.6 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.3 |
1.9 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.3 |
3.3 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.3 |
1.7 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.3 |
0.8 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.3 |
0.3 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.3 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
1.1 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.3 |
0.5 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
1.6 |
GO:0086064 |
cell communication by electrical coupling involved in cardiac conduction(GO:0086064) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.3 |
1.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
0.8 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.3 |
0.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
0.8 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.3 |
1.6 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.3 |
0.5 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.3 |
0.8 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
10.3 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.3 |
2.6 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 |
0.3 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
6.0 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
1.0 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.3 |
0.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
0.5 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.3 |
0.3 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.3 |
0.3 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.3 |
2.8 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.3 |
1.3 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein depolymerization(GO:1901881) |
| 0.3 |
2.3 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 |
1.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.2 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.2 |
1.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
1.5 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.2 |
0.5 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.2 |
1.2 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.2 |
1.7 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
1.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
9.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
1.9 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.2 |
1.0 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.2 |
0.7 |
GO:1902837 |
amino acid import into cell(GO:1902837) |
| 0.2 |
2.4 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.2 |
4.6 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
0.7 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.2 |
0.7 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
1.0 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
2.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
0.7 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.2 |
3.6 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 |
0.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.2 |
0.5 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.2 |
0.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.2 |
0.7 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.2 |
1.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.2 |
0.9 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 |
0.7 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
0.2 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 |
0.2 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.2 |
6.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.2 |
2.1 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.2 |
2.3 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.2 |
1.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.2 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
0.7 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.2 |
0.7 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 |
0.7 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.2 |
0.9 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 |
1.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
3.1 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 |
1.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
1.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.2 |
0.4 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 |
1.1 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.2 |
0.2 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
2.0 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
3.0 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
0.9 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.2 |
0.4 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
2.8 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.2 |
0.6 |
GO:0090285 |
regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 |
0.4 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.2 |
0.2 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.2 |
1.5 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 |
0.4 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 |
1.5 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.2 |
2.5 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.2 |
0.2 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.2 |
1.7 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 |
0.8 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
0.8 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
0.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
0.2 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.4 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.2 |
0.8 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
1.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
1.0 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.2 |
0.4 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.2 |
0.4 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.2 |
1.6 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.6 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.2 |
0.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
2.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
0.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.6 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.2 |
1.4 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
0.2 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.2 |
1.0 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
2.7 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.2 |
0.6 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.4 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 |
2.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.2 |
2.9 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 |
0.4 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.8 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.9 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.2 |
1.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.2 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 |
0.8 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.2 |
0.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.2 |
0.6 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
1.3 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.2 |
1.7 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
1.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
0.6 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.9 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.2 |
0.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.2 |
0.5 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.2 |
0.7 |
GO:0034349 |
glial cell apoptotic process(GO:0034349) |
| 0.2 |
4.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
2.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 |
1.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
0.5 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
0.2 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.2 |
0.5 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
0.7 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 |
0.5 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
1.6 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.2 |
0.9 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
9.8 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.2 |
0.5 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.2 |
0.3 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.2 |
2.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
0.9 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.2 |
1.5 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.5 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
0.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.2 |
0.2 |
GO:0072071 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) kidney smooth muscle tissue development(GO:0072194) metanephric glomerulus vasculature development(GO:0072239) |
| 0.2 |
0.2 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.2 |
0.3 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
| 0.2 |
0.2 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.2 |
0.5 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.2 |
0.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
0.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.8 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
0.2 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.2 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.2 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
0.5 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
0.2 |
GO:0045625 |
regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.2 |
1.0 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.2 |
0.6 |
GO:0070071 |
proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.2 |
0.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
0.5 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
0.2 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 |
1.6 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 |
0.3 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.2 |
0.3 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
0.9 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
0.3 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.2 |
0.3 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 |
1.2 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.1 |
0.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.0 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.4 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
1.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.1 |
0.4 |
GO:0036230 |
granulocyte activation(GO:0036230) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.7 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
1.6 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
4.1 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
2.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.3 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 |
2.5 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
1.2 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.3 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
1.6 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
3.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
3.3 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.3 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.4 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.1 |
0.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.3 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 |
2.1 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
0.7 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
1.1 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
1.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.7 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.7 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.4 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
| 0.1 |
1.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.1 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.1 |
0.3 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
1.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
1.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.3 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
1.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
3.0 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.1 |
GO:0050665 |
detection of oxygen(GO:0003032) hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.1 |
0.5 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
2.1 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
| 0.1 |
1.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
2.5 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.3 |
GO:0009110 |
vitamin biosynthetic process(GO:0009110) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.4 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.3 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
0.9 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.1 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.1 |
0.6 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.6 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
1.5 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.5 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.5 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.6 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.9 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.4 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.1 |
0.9 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
5.7 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.1 |
1.7 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
0.2 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.1 |
0.5 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.5 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.1 |
0.9 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.1 |
5.8 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.3 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 |
0.5 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.9 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.3 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
0.1 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.1 |
0.1 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.1 |
0.1 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.1 |
0.3 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
2.3 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
0.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.9 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
1.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.1 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 |
0.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.3 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
0.7 |
GO:0045990 |
carbon catabolite regulation of transcription(GO:0045990) |
| 0.1 |
0.3 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.8 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.1 |
0.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.3 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 |
0.1 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
1.9 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.2 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.2 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.7 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
1.5 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.4 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.2 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.1 |
0.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 |
1.2 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.4 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.4 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
1.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
3.8 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
1.8 |
GO:0045047 |
protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.1 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.3 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.2 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.9 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.4 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.1 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.1 |
0.7 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.8 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
0.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.7 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.5 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.9 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.3 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.7 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 0.1 |
0.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
4.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.8 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.6 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
1.4 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
0.2 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.2 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.1 |
0.3 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.5 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.2 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.6 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.2 |
GO:0060956 |
stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardial cell differentiation(GO:0060956) |
| 0.1 |
0.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.2 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.1 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.1 |
0.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.2 |
GO:1902307 |
positive regulation of sodium ion transmembrane transport(GO:1902307) |
| 0.1 |
0.4 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.4 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
1.9 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.1 |
0.4 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.1 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.1 |
GO:0099504 |
synaptic vesicle cycle(GO:0099504) |
| 0.1 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.5 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
1.1 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.1 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.1 |
0.6 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.6 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.4 |
GO:0014887 |
cardiac muscle adaptation(GO:0014887) |
| 0.1 |
0.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.3 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
0.5 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.1 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.2 |
GO:0019068 |
virion assembly(GO:0019068) |
| 0.1 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.3 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.1 |
0.3 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.2 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.1 |
0.4 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.5 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
1.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.1 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.1 |
0.4 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
1.7 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.5 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.3 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
0.2 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.4 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.8 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.2 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
| 0.0 |
0.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.1 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
1.2 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.0 |
0.2 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 |
0.2 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
1.7 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.0 |
0.2 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.5 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.1 |
GO:0098901 |
regulation of cardiac muscle cell action potential(GO:0098901) |
| 0.0 |
0.3 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.3 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.0 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.5 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.3 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.2 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.1 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
4.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.4 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.3 |
GO:0050777 |
negative regulation of immune response(GO:0050777) |
| 0.0 |
0.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0032305 |
positive regulation of icosanoid secretion(GO:0032305) |
| 0.0 |
0.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.0 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.1 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 |
0.4 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
0.2 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
2.6 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.1 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.0 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.0 |
0.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.0 |
0.7 |
GO:0070588 |
calcium ion transmembrane transport(GO:0070588) |
| 0.0 |
0.8 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.0 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.6 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.6 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.0 |
0.2 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.3 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.0 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.0 |
5.2 |
GO:0007264 |
small GTPase mediated signal transduction(GO:0007264) |
| 0.0 |
0.0 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.2 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.0 |
0.3 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
1.2 |
GO:1903747 |
regulation of protein targeting to mitochondrion(GO:1903214) regulation of establishment of protein localization to mitochondrion(GO:1903747) |
| 0.0 |
0.1 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.0 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.0 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
